List of SBIR/STTR awards granted to Cumberland Pharmaceuticals

List of SBIR/STTR awards granted to Cumberland Pharmaceuticals

List of SBIR/STTR awards granted to MSNW, LLC

List of SBIR/STTR awards granted to Lynntech Inc.

List of SBIR/STTR awards granted to DULY RESEARCH, INC.

List of Spreadtrum Communications patents

List of companies in Acuity Brands's investment portfolio

where

SBIR/STTR Award Recipient

is

Cumberland Pharmaceuticals

	Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
	‌ CUMBERLAND PHARMACEUTICALS INC. SBIR Phase II Award, September 2018	A SBIR Phase II contract was awarded to Cumberland Pharmaceuticals in September, 2018 for $1,994,205.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Cumberland Pharmaceuticals		National Institutes of Health	SBIR	9R44CA228756-02	Phase II	1,994,205	September 11, 2018	sbir.gov/node/1566997
	‌ CUMBERLAND PHARMACEUTICALS INC. STTR Phase I Award, September 2016	A STTR Phase I contract was awarded to Cumberland Pharmaceuticals in September, 2016 for $224,999.0 USD from the U.S. Department of Health & Human Services.	Cumberland Pharmaceuticals			STTR	1R41DK106779-01A1	Phase I	224,999	September 1, 2016	sbir.gov/node/1195453
	‌ CUMBERLAND PHARMACEUTICALS INC. STTR Phase II Award,	A STTR Phase II contract was awarded to Cumberland Pharmaceuticals for $749,143.0 USD from the U.S. Department of Health & Human Services.	Cumberland Pharmaceuticals			STTR	2R42HL064530-02	Phase II	749,143		sbir.gov/content/tgf-beta-pleurodesis-0
	‌ CUMBERLAND PHARMACEUTICALS INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to Cumberland Pharmaceuticals for $749,143.0 USD from the U.S. Department of Health & Human Services.	Cumberland Pharmaceuticals			SBIR	2R42HL064530-02	Phase II	749,143		sbir.gov/node/1066785
	‌ CUMBERLAND PHARMACEUTICALS INC. STTR Phase I Award,	A STTR Phase I contract was awarded to Cumberland Pharmaceuticals for $111,805.0 USD from the U.S. Department of Health & Human Services.	Cumberland Pharmaceuticals			STTR	1R41HL090108-01A2	Phase I	111,805		sbir.gov/content/mannan-potential-therapeutic-asthma-0
	‌ CUMBERLAND PHARMACEUTICALS INC. STTR Phase I Award,	A STTR Phase I contract was awarded to Cumberland Pharmaceuticals for $110,644.0 USD from the U.S. Department of Health & Human Services.	Cumberland Pharmaceuticals			STTR	1R41AI063935-01A1	Phase I	110,644		sbir.gov/content/high-purity-amphotericin-b-safer-antimycotic-aids-0
	‌ CUMBERLAND PHARMACEUTICALS INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Cumberland Pharmaceuticals for $110,644.0 USD from the U.S. Department of Health & Human Services.	Cumberland Pharmaceuticals			SBIR	1R41AI063935-01A1	Phase I	110,644		sbir.gov/node/1068261
	‌ CUMBERLAND PHARMACEUTICALS INC. STTR Phase I Award,	A STTR Phase I contract was awarded to Cumberland Pharmaceuticals for $121,528.0 USD from the U.S. Department of Health & Human Services.	Cumberland Pharmaceuticals			STTR	1R41CA130191-01A2	Phase I	121,528		sbir.gov/content/radioprotection-use-topical-lithium-formulations-0
	‌ CUMBERLAND PHARMACEUTICALS INC. STTR Phase I Award,	A STTR Phase I contract was awarded to Cumberland Pharmaceuticals for $246,084.0 USD from the U.S. Department of Health & Human Services.	Cumberland Pharmaceuticals			STTR	1R41AG043342-01	Phase I	246,084		sbir.gov/node/390892
	‌ CUMBERLAND PHARMACEUTICALS INC. STTR Phase I Award,	A STTR Phase I contract was awarded to Cumberland Pharmaceuticals for $224,910.0 USD from the U.S. Department of Health & Human Services.	Cumberland Pharmaceuticals			STTR	1R41ES025596-01A1	Phase I	224,910		sbir.gov/node/707643

10 results

0 selected

10 results

0 selected